Alps Advisors Inc Verastem, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$2.05 - $3.2 $454,171 - $708,950	-221,547 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $12,430 - $19,918	-4,894 Reduced 2.16%	221,547 $682,000
Q2 2021 Aug 11, 2021	SELL	$2.57 - $4.85 $207,450 - $391,492	-80,720 Reduced 26.28%	226,441 $922,000
Q1 2021 May 07, 2021	BUY	$1.9 - $2.82 $1,385 - $2,055	729 Added 0.24%	307,161 $759,000
Q4 2020 Feb 03, 2021	BUY	$1.15 - $2.4 $352,396 - $735,436	306,432 New	306,432 $653,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.